ChIp experiments revealed that YY1 occupied C/EBPα, C/EBPε, and C/EBPδ 5′ promoter regions in the AML cell lines, thus functioning in this context as a suppressor of transcription. Here, CEBPD is linked to acute myeloid leukemia.